Short Interest in Sharps Technology, Inc. (NASDAQ:STSS) Declines By 91.7%

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 367,700 shares, a decrease of 91.7% from the June 15th total of 4,440,000 shares. Approximately 1.7% of the company’s shares are short sold. Based on an average daily trading volume, of 11,010,000 shares, the short-interest ratio is currently 0.0 days.

Sharps Technology Price Performance

NASDAQ STSS traded down $0.02 during trading on Thursday, hitting $0.26. 1,002,841 shares of the company’s stock traded hands, compared to its average volume of 5,532,070. The firm has a market cap of $4.12 million, a P/E ratio of -0.44 and a beta of 1.24. The stock has a fifty day moving average of $0.28 and a two-hundred day moving average of $0.32. Sharps Technology has a 12-month low of $0.17 and a 12-month high of $0.94.

Sharps Technology (NASDAQ:STSS) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($0.05) EPS for the quarter.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.